Liam Mullen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Liam Mullen has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Aleem Khand
University Hospital Aintree, Liverpool, UK; Liverpool Heart and Chest Hospital, Liverpool, UK
2 shared publications- Ahmed Reda Gonnah
Imperial College Healthcare NHS Trust London UK
1 shared publication Fredrick Frost
University Hospital Aintree, Liverpool, UK
1 shared publication- Joel P. Giblett
Department of Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK
1 shared publication - John Y. Hung
Electrical & Computer Engineering Dept., Auburn University, AL 36849
1 shared publication - Kully Sandhu
Liverpool Heart and Chest Hospital, Liverpool, UK
1 shared publication
Latest Publications
- Open Access
- 21 March 2025
- Published by Radcliffe Medical Media Ltd in Interventional Cardiology: Reviews, Research, Resources
- Vol. 20, e10
Complete Revascularisation Following Acute MI: A Contemporary Review
Acute MI (AMI) is a leading cause of mortality globally. Swift diagnosis is imperative, with timely reperfusion crucial to minimise adverse outcomes. Revascularisation strategies include culprit-vessel-only therapy, staged complete revascularisation or immediate complete revascularisation. Evidence from randomised trials strongly favours complete revascularisation in ST-elevation MI (STEMI). Data regarding immediate complete revascularisation compared to a staged approach are limited, with uncertainties regarding the advantages of physiology-guided treatment compared to angiographic assessment alone. Non-STEMI (NSTEMI) patients with multivessel disease are often complex and current guidelines offer limited recommendations for this patient group, emphasising the need for individualised treatment. Observational studies have sought to find the optimal approach, yet conflicting data prevails. Dedicated trials for this issue in NSTEMI patients are currently unavailable. To enhance the decision-making processes for patients with AMI, future trials should consider the inclusion of functional health status and health-related quality of life outcomes. The existing gaps in knowledge underscore the intricacies of managing AMI and the ongoing necessity for comprehensive research to refine treatment strategies.
- 21 March 2025
- Published by Radcliffe Medical Media Ltd in Interventional Cardiology: Reviews, Research, Resources
- Vol. 20, e10
Open AccessComplete Revascularisation Following Acute MI: A Contemporary Review
Acute MI (AMI) is a leading cause of mortality globally. Swift diagnosis is imperative, with timely reperfusion crucial to minimise adverse outcomes. Revascularisation strategies include culprit-vessel-only therapy, staged complete revascularisation or immediate complete revascularisation. Evidence from randomised trials strongly favours complete revascularisation in ST-elevation MI (STEMI). Data regarding immediate complete revascularisation compared to a staged approach are limited, with uncertainties regarding the advantages of physiology-guided treatment compared to angiographic assessment alone. Non-STEMI (NSTEMI) patients with multivessel disease are often complex and current guidelines offer limited recommendations for this patient group, emphasising the need for individualised treatment. Observational studies have sought to find the optimal approach, yet conflicting data prevails. Dedicated trials for this issue in NSTEMI patients are currently unavailable. To enhance the decision-making processes for patients with AMI, future trials should consider the inclusion of functional health status and health-related quality of life outcomes. The existing gaps in knowledge underscore the intricacies of managing AMI and the ongoing necessity for comprehensive research to refine treatment strategies.
- 1 June 2016
- Published by Elsevier in The Lancet
- Vol. 387 (10035) , 2288-2289
Measurement of cardiac troponin for exclusion of myocardial infarction
- 1 June 2016
- Published by Elsevier in The Lancet
- Vol. 387 (10035) , 2288-2289
Measurement of cardiac troponin for exclusion of myocardial infarction
- 1 June 2016
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 32 (6) , 830.e9-830.e10
Very Late Stent Thrombosis: The Value of Optical Coherence Tomography in Defining Etiology and Guiding Treatment
- 1 June 2016
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 32 (6) , 830.e9-830.e10
Very Late Stent Thrombosis: The Value of Optical Coherence Tomography in Defining Etiology and Guiding Treatment